Full dossier in preparation
Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Process with priority
Sign in free to move this company to the front.
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of PEVO is 0.3% (very low). The 2024 annual accounts show equity of €526k and a net result of €628k. Equity is growing by ~12.7% per year across the filed fiscal years. Its solvency ranks better than 37% of 36 sector peers (fiscal year 2024). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 7 annual accounts.
Signals
1 signal · with evidenceConsistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 11 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-02-2025, 153 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 28-02-2025 | 153 d early | 2025-00040775 |
| 31-12-2023 | 31-07-2024 | 21-06-2024 | 40 d early | 2024-00151860 |
| 31-12-2022 | 31-07-2023 | 22-06-2023 | 39 d early | 2023-00146153 |
| 31-12-2021 | 31-07-2022 | 05-07-2022 | 26 d early | 2022-20132262 |
| 31-12-2020 | 31-07-2021 | 22-07-2021 | 9 d early | 2021-38000596 |
| 31-12-2019 | 31-07-2020 | 23-07-2020 | 8 d early | 2020-32600171 |
| 31-12-2018 | 31-07-2019 | 23-07-2019 | 8 d early | 2019-35900400 |
| 31-12-2017 | 31-07-2018 | 04-07-2018 | 27 d early | 2018-27500382 |
| 31-12-2016 | 31-07-2017 | 05-07-2017 | 26 d early | 2017-27800408 |
| 31-12-2015 | 31-07-2016 | 06-07-2016 | 25 d early | 2016-28200144 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsLong-established
Founded in 2006, 20 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Multiple establishment units
+Long track record
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€628k+11.8%
Working capital€-287k
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 28-02-2025 with the NBB · fiscal year 2024 · verkort
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~12.7%/year over 7 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 32 · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 13.8% | 24.8% | |
| Net result | €628k | €17k | |
| Equity | €526k | €183k | |
| Gross operating margin | €4.97M | €138k | |
| Total assets | €3.80M | €675k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€1.18M
+12.3%
18-24
€628k
+11.8%
18-24
€867k
+6.9%
18-24
€3.80M
+11.0%
18-24
€526k
-69.9%
18-24
€-287k
-
18-24
63
+4.9%
18-24
€3.77M
+6.9%
18-24
€247k
+19.0%
18-24
€1.85M
-
18-24
€3.27M
+95.3%
18-24
€3.16M
+103.5%
18-24
€75k
+7.4%
18-24
0.91
-44.8%
18-24
0.83
-44.9%
18-24
13.8%
-72.9%
18-24
6.22
+548.8%
18-24
119.4%
+271.6%
18-24
16.5%
+0.8%
18-24
17.64
+13.1%
18-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €1.18M |
| Net profit | €628k |
| Cash flow | €867k |
| Staff costs | €3.77M |
| Income taxes | €247k |
| Dividends | €1.85M |
| Total assets | €3.80M |
| Equity | €526k |
| Debt | €3.27M |
| of which ≤ 1y | €3.16M |
| of which > 1y | €75k |
| Working capital | €-287k |
| Employees (FTE) | 62.5 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.91 |
| Quick ratio | 0.83 |
| Working capital ratio | -7.6% |
| Solvency | 13.8% |
| Debt / equity | 6.22 |
| Long-term debt ratio | 0.14 |
| Interest coverage | 17.64 |
| Gross margin | - |
| Net margin | - |
| ROA | 16.5% |
| ROE | 119.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.80M |
| Fixed assets | 21/28 | €930k |
| Tangible fixed assets | 22/27 | €890k |
| Financial fixed assets | 28 | €40k |
| Current assets | 29/58 | €2.87M |
| Stocks & contracts in progress | 3 | €255k |
| Amounts receivable within one year | 40/41 | €1.65M |
| Investments | 50/53 | €572k |
| Cash & bank | 54/58 | €396k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.80M |
| Equity | 10/15 | €526k |
| Contributions / capital | 10/11 | €81k |
| Reserves | 13 | €446k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €3.27M |
| Amounts payable after one year | 17 | €75k |
| Amounts payable within one year | 42/48 | €3.16M |
| Trade debts payable within one year | 44 | €854k |
| Income statement | ||
| Gross operating margin | 9900 | €4.97M |
| Operating result | 9901 | €942k |
| Financial income | 75 | €41k |
| Financial charges | 65 | €67k |
| Result before taxes | 9903 | €875k |
| Income taxes | 67/77 | €247k |
| Net result for the period | 9904 | €628k |
| Result to be appropriated | 9905 | €628k |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed53
/ 100
Fair
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Directors
Directors & mandates
5 directorsCurrent directors & mandates
-
Current22-01-2018 → present
2 events
- 03-06-2024 Mandate renewed· Director
- 22-01-2018 Mandate renewed· Director
-
Current22-01-2018 → present
4 events
- 03-06-2024 Mandate renewed· Director
- 03-06-2024 Mandate renewed· Managing director
- 11-04-2018 Appointed· Managing director
- 22-01-2018 Mandate renewed· Director
Historic, not recently confirmed (1)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
EJAMUNLegal entityManaging director· perm. rep.: Van Hacht JosephState Gazette act 18059559 (11-04-2018)Not recently confirmedlast confirmed in an act from 2018
2 events
- 11-04-2018 Appointed· Managing director
- 22-01-2018 Mandate renewed· Director
Former directors (2)
-
Ejamun bvLegal entityDirector· perm. rep.: Thomas QuisquaterState Gazette act 22097930 (16-08-2022)Former- → 25-05-2022
2 events
- 25-05-2022 Resigned· Director
- 25-05-2022 Resigned· Managing director
-
Former- → 22-01-2018
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500) |
| Legal form | Public limited company(014) |
| Incorporation | 19-05-2006 |
| Status | Active |
| Postal code | 2460 |
Structure & network
Connections & network
3 connected companiesGroup structure
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary
Control→
Network connections
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Locations & real estate
Registered office
on the map · from the address register
Kasterlee
exact location from the address register
Establishment units
2 locationsPEVO
since 20062.155.102.547
PEVO
since 20062.155.102.646
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area3,403 m²
Buildings2
Building footprint1,477 m²
Volume (LiDAR)3,778 m³
Tallest building28.5 m · ±2 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13038C0880/00A000 | Flanders | 2,751 m² | 1 · 1,276 m² | 28.5 m |
| 11021A0004/00F002 | Flanders | 652 m² | 1 · 201 m² | 10.0 m · 2 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
6 acts Address history · 2
03-06-2026
Seat change: adres uit statuten verwijderd, enkel Gewest vermeld
25-07-2018
v3.2
All acts · 6
updated 2 months ago
2026
03-06-2026 General meeting · Statute amendment · Seat change · Purpose change
- Filing: 2026-06-01 · PEVO
- General meeting: 2026-05-27 · PEVO
- Statute amendment: coordinatie WVV · PEVO
- Seat change: adres uit statuten verwijderd, enkel Gewest vermeld · PEVO
- Purpose change: vervanging voorwerp · PEVO
- Governance rule: enige bestuurder · PEVO
- Officer resignation: 2026-05-27 · VAN WESENBEECK Mieke
- Officer discharge · VAN WESENBEECK Mieke
- Mandate term: onbepaalde duur · VAN WESENBEECK Mieke
- Permanent representative · QUISQUATER Thomas
- Statute amendment: nieuwe tekst statuten · PEVO
- Auditor waiver · PEVO
- Power of attorney: bijzondere mandataris · PEVO
- Officer appointment: directeur dagelijks bestuur · VAN WESENBEECK Mieke
- Annual meeting schedule: eerste maandag van juni om 17:00 uur · PEVO
- First fiscal year: 01-01 tot 31-12 · PEVO
- Publication: 2026-06-03
- Act object: ONTSLAGEN, BENOEMINGEN
Summary:
General meeting · Statute amendment · Seat change · Purpose changeNotary:
Peter Timmermans
2024
05-08-2024 3 reappointed
- Thomas Quisquater, Bestuurder
- Mieke Van Wesenbeeck, Bestuurder
- Thomas Quisquater, Gedelegeerd bestuurder
Summary:
v3.2
2022
16-08-2022 2 resigning
- Thomas Quisquater, Bestuurder
- Thomas Quisquater, Gedelegeerd bestuurder
Summary:
v3.2
2018
25-07-2018 Registered office moved from Turnhout to Kasterlee
- Kempenlaan 59, 2300 Turnhout → Kemelbeekstraat 1, 2460 Kasterlee
Summary:
v3.2
11-04-2018 2 directors appointed, 1 resigning, 3 reappointed
- Van Hacht Joseph, Gedelegeerd bestuurder
- Quisquater Thomas, Gedelegeerd bestuurder
- Sleeckx Karolien, Bestuurder
- Van Hacht Joseph, Bestuurder
- Quisquater Thomas, Bestuurder
- Van Wesenbeeck Mieke, Bestuurder
Summary:
v3.2
2017
18-01-2017 Articles of association amended
Summary:
v3.2
Analysis
Snowflake analysis
financial profile on 5 axes66
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
53
Profitability
100
Solvency
18
Growth
58
Stability
100
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van orthopedische artikelen en prothesen33103
Primary activity highlighted.
Names & trade names
| Legal nameNL | PEVO |
Registered office
Kemelbeekstraat 1
2460 Kasterlee, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.